These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9416386)

  • 1. Extrapyramidal reactions and the selective serotonin-reuptake inhibitors.
    Caley CF
    Ann Pharmacother; 1997 Dec; 31(12):1481-9. PubMed ID: 9416386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrapyramidal Reactions Associated with Serotonergic Antidepressants.
    Hawthorne JM; Caley CF
    Ann Pharmacother; 2015 Oct; 49(10):1136-52. PubMed ID: 26185277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrapyramidal effects of SSRI antidepressants.
    Prescrire Int; 2001 Aug; 10(54):118-9. PubMed ID: 11718183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrapyramidal reactions to SSRI antidepressant + neuroleptic combinations.
    Prescrire Int; 2004 Apr; 13(70):57. PubMed ID: 15148974
    [No Abstract]   [Full Text] [Related]  

  • 5. Movement disorders associated with the serotonin selective reuptake inhibitors.
    Leo RJ
    J Clin Psychiatry; 1996 Oct; 57(10):449-54. PubMed ID: 8909330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between selective serotonin-reuptake inhibitors, second-generation antipsychotics, and neuroleptic malignant syndrome.
    Stevens DL
    Ann Pharmacother; 2008 Sep; 42(9):1290-7. PubMed ID: 18628446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment.
    Lane RM
    J Psychopharmacol; 1998; 12(2):192-214. PubMed ID: 9694033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms.
    Hedenmalm K; Güzey C; Dahl ML; Yue QY; Spigset O
    J Clin Psychopharmacol; 2006 Apr; 26(2):192-7. PubMed ID: 16633151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review.
    Damsa C; Bumb A; Bianchi-Demicheli F; Vidailhet P; Sterck R; Andreoli A; Beyenburg S
    J Clin Psychiatry; 2004 Aug; 65(8):1064-8. PubMed ID: 15323590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective serotonin-reuptake inhibitor-induced movement disorders.
    Gerber PE; Lynd LD
    Ann Pharmacother; 1998 Jun; 32(6):692-8. PubMed ID: 9640489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extrapyramidal reactions and neuroleptic malignant syndrome].
    Gómez EA
    Acta Psiquiatr Psicol Am Lat; 1984 Dec; 30(4):281-6. PubMed ID: 6535382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Movement disorders induced by psychiatric drugs that do not block dopamine receptors.
    Friedman JH
    Parkinsonism Relat Disord; 2020 Oct; 79():60-64. PubMed ID: 32871538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SSRI antidepressants: extrapyramidal reactions.
    Prescrire Int; 2016 Apr; 25(170):100. PubMed ID: 27227172
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitor-induced akathisia.
    Koliscak LP; Makela EH
    J Am Pharm Assoc (2003); 2009; 49(2):e28-36; quiz e37-8. PubMed ID: 19289334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrapyramidal symptoms associated with antidepressants--a review of the literature and an analysis of spontaneous reports.
    Madhusoodanan S; Alexeenko L; Sanders R; Brenner R
    Ann Clin Psychiatry; 2010 Aug; 22(3):148-56. PubMed ID: 20680187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case-control study using spontaneous reports.
    Schillevoort I; van Puijenbroek EP; de Boer A; Roos RA; Jansen PA; Leufkens HG
    Int Clin Psychopharmacol; 2002 Mar; 17(2):75-9. PubMed ID: 11892721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective serotonin reuptake inhibitor-related extrapyramidal symptoms in autistic children: a case series.
    Sokolski KN; Chicz-Demet A; Demet EM
    J Child Adolesc Psychopharmacol; 2004; 14(1):143-7. PubMed ID: 15142402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrapyramidal symptoms with selective serotonin reuptake inhibitors.
    Arya DK
    Br J Psychiatry; 1994 Dec; 165(6):728-33. PubMed ID: 7881774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrapyramidal symptoms associated with cyclic antidepressant treatment: a review of the literature and consolidating hypotheses.
    Gill HS; DeVane CL; Risch SC
    J Clin Psychopharmacol; 1997 Oct; 17(5):377-89. PubMed ID: 9315989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study.
    Avorn J; Bohn RL; Mogun H; Gurwitz JH; Monane M; Everitt D; Walker A
    Am J Med; 1995 Jul; 99(1):48-54. PubMed ID: 7598142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.